On June 18th, Hangzhou Tigermed Consulting Co., Ltd. (stock code: 03347) spent 21.61 million RMB to repurchase 542,400 shares of A-shares.
Tiger Pharmaceuticals (03347) announced that on June 18, 2026, the company spent 21.6163 million yuan to repurchase 542,400 A shares.
Hangzhou Tigermed Consulting (03347) announced on June 18, 2026, that the company will spend 21.61 million yuan to repurchase 542,400 shares of A shares.
Related Articles
Beijing Tieke Shougang Railway-Tech (688569.SH): Metallurgical Tianyu plans to reduce its holdings by no more than 1% of its shares.
Tencent (00700) spent HK$501 million on June 18 to repurchase 1.144 million shares.
QYUNS-B (02509) spent HK$157,100 to repurchase 11,000 shares on June 18th.
Beijing Tieke Shougang Railway-Tech (688569.SH): Metallurgical Tianyu plans to reduce its holdings by no more than 1% of its shares.
Tencent (00700) spent HK$501 million on June 18 to repurchase 1.144 million shares.
QYUNS-B (02509) spent HK$157,100 to repurchase 11,000 shares on June 18th.
RECOMMEND
